The impact of common germline risk on somatic alterations and clinical features across cancers

被引：0
|
作者：
Saito, Yuki [1 ,2 ]
Namba, Shinichi [3 ]
Kogure, Yasunori [1 ]
Okada, Yukinori [3 ,4 ,5 ]
Kataoka, Keisuke [1 ,6 ]
机构：
[1] Natl Canc Ctr, Div Mol Oncol, Res Inst, Tokyo, Japan
[2] Keio Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan
[3] Osaka Univ, Dep Stat Genet, Grad Sch Med, Osaka, Japan
[4] RIKEN Ctr Integrat Med Sci, Lab Syst Genet, Yokohama, Japan
[5] Univ Tokyo, Grad Sch Med, Dept Cell Signal, Tokyo, Japan
[6] Keio Univ, Div Hematol, Dept Med, Sch Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S8-5
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [31] Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race-ethnicity
    Chen, Yalei
    Li, Jia
    Sadasivan, Sudha
    She, Ruicong
    Datta, Indrani
    Chitale, Dhananjay
    Gupta, Nilesh
    Davis, Melissa B.
    Rogers, Craig G.
    Newman, Lisa A.
    Paris, Pamela L.
    Rybicki, Benjamin A.
    Levin, Albert M.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival
    Chen, Yalei
    Sadasivan, Sudha M.
    She, Ruicong
    Datta, Indrani
    Taneja, Kanika
    Chitale, Dhananjay
    Gupta, Nilesh
    Davis, Melissa B.
    Newman, Lisa A.
    Rogers, Craig G.
    Paris, Pamela L.
    Li, Jia
    Rybicki, Benjamin A.
    Levin, Albert M.
    BMC MEDICAL GENOMICS, 2020, 13 (01)
  • [33] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1403 - 1403
  • [34] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1403 - 1403
  • [35] Gastric cancers with microsatellite instability sharing clinical features, chemoresistance and germline MSH6 variants
    Yamashita K.
    Arimura Y.
    Saito M.
    Suzuki H.
    Furuhata T.
    Hirata K.
    Shinomura Y.
    Clinical Journal of Gastroenterology, 2013, 6 (2) : 122 - 126
  • [36] Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
    Zhang, Yan Dora
    Hurson, Amber N.
    Zhang, Haoyu
    Choudhury, Parichoy Pal
    Easton, Douglas F.
    Milne, Roger L.
    Simard, Jacques
    Hall, Per
    Michailidou, Kyriaki
    Dennis, Joe
    Schmidt, Marjanka K.
    Chang-Claude, Jenny
    Gharahkhani, Puya
    Whiteman, David
    Campbell, Peter T.
    Hoffmeister, Michael
    Jenkins, Mark
    Peters, Ulrike
    Hsu, Li
    Gruber, Stephen B.
    Casey, Graham
    Schmit, Stephanie L.
    O'Mara, Tracy A.
    Spurdle, Amanda B.
    Thompson, Deborah J.
    Tomlinson, Ian
    De Vivo, Immaculata
    Landi, Maria Teresa
    Law, Matthew H.
    Iles, Mark M.
    Demenais, Florence
    Kumar, Rajiv
    MacGregor, Stuart
    Bishop, D. Timothy
    Ward, Sarah V.
    Bondy, Melissa L.
    Houlston, Richard
    Wiencke, John K.
    Melin, Beatrice
    Barnholtz-Sloan, Jill
    Kinnersley, Ben
    Wrensch, Margaret R.
    Amos, Christopher I.
    Hung, Rayjean J.
    Brennan, Paul
    McKay, James
    Caporaso, Neil E.
    Berndt, Sonja I.
    Birmann, Brenda M.
    Camp, Nicola J.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [37] Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
    Yan Dora Zhang
    Amber N. Hurson
    Haoyu Zhang
    Parichoy Pal Choudhury
    Douglas F. Easton
    Roger L. Milne
    Jacques Simard
    Per Hall
    Kyriaki Michailidou
    Joe Dennis
    Marjanka K. Schmidt
    Jenny Chang-Claude
    Puya Gharahkhani
    David Whiteman
    Peter T. Campbell
    Michael Hoffmeister
    Mark Jenkins
    Ulrike Peters
    Li Hsu
    Stephen B. Gruber
    Graham Casey
    Stephanie L. Schmit
    Tracy A. O’Mara
    Amanda B. Spurdle
    Deborah J. Thompson
    Ian Tomlinson
    Immaculata De Vivo
    Maria Teresa Landi
    Matthew H. Law
    Mark M. Iles
    Florence Demenais
    Rajiv Kumar
    Stuart MacGregor
    D. Timothy Bishop
    Sarah V. Ward
    Melissa L. Bondy
    Richard Houlston
    John K. Wiencke
    Beatrice Melin
    Jill Barnholtz-Sloan
    Ben Kinnersley
    Margaret R. Wrensch
    Christopher I. Amos
    Rayjean J. Hung
    Paul Brennan
    James McKay
    Neil E. Caporaso
    Sonja I. Berndt
    Brenda M. Birmann
    Nicola J. Camp
    Nature Communications, 11
  • [38] Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: implications for germline testing and clinical management
    Sheikh, Rania
    Truong, Hong
    Khurram, Aliya
    Kemel, Yelena
    Vijay, Joseph
    Mandelker, Diana
    Ceyhan-Birsoy, Ozgy
    Latham, Alicia
    Walsh, Michael
    Liu, Ying
    Goh, Alvin
    Donahue, Timothy
    Cha, Eugene
    Coleman, Jonathan
    Pietzak, Eugene
    Stadler, Zsofia
    Offit, Kenneth
    Carlo, Maria
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S33 - S33
  • [39] The acceptability and clinical impact of using polygenic scores for risk-estimation of common cancers in primary care: a systematic review
    Dannhauser, Faye C.
    Taylor, Lily C.
    Tung, Joanna S. L.
    Usher-Smith, Juliet A.
    JOURNAL OF COMMUNITY GENETICS, 2024, 15 (03) : 217 - 234
  • [40] Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making
    Jorge, Soledad
    McFaddin, Andrew S.
    Doll, Kemi M.
    Pennington, Kathryn P.
    Norquist, Barbara M.
    Bennett, Robin L.
    Pritchard, Colin C.
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 517 - 522
12345